AYURVEDIC MANAGEMENT OF METABOLIC SYNDROME: A CRITICAL REVIEW OF MEDOVAHA SROTAS PATHOLOGY AND INTERVENTION STRATEGIES
Main Article Content
Keywords
Metabolic Syndrome, Medovaha Srotas, Agni mandya, Sthaulya , Prameha, Guggulu, Curcumin, Insulin Resistance, Santarpana, Virechana .
Abstract
Metabolic Syndrome (MetS) has emerged as a predominant global health crisis, characterized by a complex cluster of risk factors including central obesity, insulin resistance, dyslipidemia, and hypertension. This study provides a comprehensive research paper drafted from the perspective of an advanced researcher in Ayurveda, aimed at correlating the modern biomedical constructs of MetS with the Ayurvedic principles of Medovaha Srotas pathology. The investigation explores the anatomical and physiological foundations of Meda Dhatu (adipose tissue) and its transport channels, Medovaha Srotas, identifying their Moolasthana (roots) in the Vrikka (kidney) and Vapavahana (omentum) as per classical Samhita descriptions. Through a critical review of Charaka Samhita, Sushruta Samhita, and Ashtanga Hridaya, the paper delineates the etiology of Santarpanottha Vyadhi (over-nutrition disorders) and the role of Agni mandya (metabolic impairment) and Ama (endotoxins) in driving systemic inflammation and insulin resistance. The management strategy integrates Shodhana (biopurification) therapies such as Virechana and Udvartana with Shamana (palliative) interventions involving evidence-based herbs like Guggulu, Haridra (Curcumin), and Triphala. Modern pharmacological pathways, including the modulation of PPAR-gamma, TNF-alpha, and gut microbiota, are synthesized with Ayurvedic concepts to provide a multi-dimensional treatment framework. This research highlights the efficacy of an integrated Ayurvedic approach in managing metabolic biomarkers and reducing the risk of cardiovascular morbidity and type 2 diabetes.[i]
References
2. Hauser, S. L., Longo, D. L., & Jameson, J. L. (Eds.). (2022). Harrison's Principles of Internal Medicine (21st ed.). McGraw Hill Education. https://doi.org/10.1036/0071802150
3. 19. GBD 2015 Obesity Collaborators. (2017). Health Effects of Overweight and Obesity in 195 Countries over 25 Years. New England Journal of Medicine, 377, 13-27. https://doi.org/10.1056/NEJMoa1614362
4. Shastri, K., & Chaturvedi, G. N. (Eds.). (2012). Charaka Samhita (Vidyotini Hindi Commentary). Vimana Sthana, Chapter 5 (Sroto Vimana), Shloka 8, Page 510. Chaukhambha Bharati Academy.
5. Shastri, K., & Chaturvedi, G. N. (Eds.). (2012). Charaka Samhita (Vidyotini Hindi Commentary). Sutra Sthana, Chapter 23 (Santarpaniya Adhyaya), Shloka 3-8, Page 295. Chaukhambha Bharati Academy.
6. Shastri, A. D. (Ed.). (2024). Sushruta Samhita (Ayurved-Tattva-Sandeepika Hindi Commentary). Sutra Sthana, Chapter 15, Shloka 5, Page 68. Chaukhambha Sanskrit Sansthan.
7. Sharma, H., & Chandola, H. M. (2011). Ayurvedic concept of obesity, metabolic syndrome, and diabetes mellitus. The Journal of Alternative and Complementary Medicine, 17(6), 549-552. https://doi.org/10.1089/acm.2010.0690
8. Shastri, A. D. (Ed.). (2024). Sushruta Samhita (Ayurved-Tattva-Sandeepika Hindi Commentary). Sutra Sthana, Chapter 9 (DoshaDhatumala kshayavruddhi Vijnaniya Adhyaya), Shloka 12, Page 67. Chaukhambha Sanskrit Sansthan.
9. Tripathi, B. (Ed.). (2014). Ashtanga Hridayam (Nirmala Hindi Commentary). Sutra Sthana, Chapter 11 (Dosha-adi-vijnaniya Adhyaya), Shloka 1-17, Page 113. Chaukhambha Sanskrit Sansthan.
10. Patel, H., & Tank, N. (2026). Decoding the Yakrut-Meda s Axis: MASLD in the Framework of Medovaha Sroto-Dushti. International Journal of Ayurveda and Pharma Research, 13(12), 129-135. https://doi.org/10.47070/ijapr.v13i12.3912
11. Garasia, J. S., & Goyal, M. (2021). Effect of Triphala Kajjali tablet for the management of metabolic syndrome: a single case study. International Journal of Advances in Medicine, 8(12), 1876-1880. https://doi.org/10.18203/2349-3933.ijam20214528
12. Chaturvedi, A., Nath, G., Yadav, V. B., & Singh, J. P. (2020). A clinical study on Virechana Karma (therapeutic purgation) over gut microbiota in obesity. Journal of Ayurveda and Integrative Medicine, 11(4), 405-411. https://doi.org/10.1016/j.jaim.2020.06.002
13. Tabrizi, R., et al. (2023). The effects of curcumin supplement on metabolic indices in patients with metabolic syndrome: A systematic review and meta-analysis. Frontiers in Endocrinology, 14, 1216708. https://doi.org/10.3389/fendo.2023.1216708
14. Fadnavis, K. K., Rathi, R. B., et al. (2025). Evaluation of the Comparative Efficacy of Navak Guggulu in the Management of Sthaulya : A Randomized Controlled Trial. JMIR Research Protocols, 14, e58838. https://doi.org/10.2196/58838
15. Bairwa, V. K., Kashyap, A. K., Meena, P., & Jain, B. P. (2025). Triphala’s characteristics and potential therapeutic uses in modern health. International Journal of Physiology, Pathophysiology and Pharmacology, 17(2), 19-36. https://doi.org/10.62347/OBSS5026
16. Shukla, S., et al. (2024). Efficacy of tryushnadi churna in metabolic syndrome with obesity: A randomized double blind controlled clinical trial. Journal of Ayurveda and Integrative Medicine, 15(4), 100973. https://doi.org/10.1016/j.jaim.2024.100973
17. Deliwala, K., & Deole, Y. S. (2025). Ayurvedic perspective of mitochondrial dysfunction and vitiation of Meda Dhatu in obesity (Sthaulya ). Journal of Drug Research in Ayurvedic Sciences, 10(Suppl 2), S144-S150. https://doi.org/10.4103/jdras.jdras_10_25
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr Mahendra Kumar Sourtha
Senior Medical Officer -1, Govt. Ayurved Hospital, Anokhu, Sikar, Department of Ayurved, Govt. of Rajasthan
Dr. Ramesh Kumar
Ayurved Medical Officer,Govt Ayurved Hospital, Banthod, Sikar , Department of Ayurved, Govt. of Rajasthan
